I bought in to the well hated spp to. I think Mason is significantly contributing to the discussion on IMU. I have to admit his scientific reasoning is over my head. This is a speculative situation but probably over the next 6 months things will become more tangible. I am happy to hold. My opinion based on what I hear and observe in the media and life is that there is a massive unmet need for cancer therapies that are effective and have minimal side effects. IMU's got 4 or 5 different products that are being progressed and some are reaching critical trial stages. It is probably unrealistic to expect all to succeed. If they do the job I have no doubt some will find a market. I anticipate many people currently being treated with chemotherapy will instead be given immunotherapy drugs. Mason could be right but lets see how the trials go.
You dont often get something for nothing. This opportunity has a risk of failure but the upside is enormous.
- Forums
- ASX - By Stock
- IMU
- From the Professor...
From the Professor..., page-136
-
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 286362 | 0.055 |
9 | 2036888 | 0.054 |
16 | 2736044 | 0.053 |
20 | 1943436 | 0.052 |
23 | 3206056 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 378902 | 2 |
0.058 | 1552127 | 7 |
0.059 | 837099 | 8 |
0.060 | 2176188 | 16 |
0.061 | 1163926 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online